Royce & Associates LP Organogenesis Holdings Inc. Transaction History

Royce & Associates LP

  • $10.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
SELL
$1.89 - $2.93 $2,424 - $3,759
-1,283 Reduced 6.66%
17,968 $38,000
Q4 2022

May 23, 2023
BUY
$2.48 - $3.43 $3,181 - $4,400
1,283 Added 7.14%
19,251 $51,000
Q4 2022

Feb 13, 2023
BUY
$2.48 - $3.43 $6,361 - $8,797
2,565 Added 15.37%
19,251 $52,000
Q3 2022

Nov 03, 2022
BUY
$3.14 - $6.43 $52,394 - $107,290
16,686 New
16,686 $54,000

Others Institutions Holding ORGO

# of Institutions
117
Shares Held
63.2M
Call Options Held
25K
Put Options Held
23.2K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $406M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email